Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Public ClinicalTrials.gov record NCT06959225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.
Study identification
- NCT ID
- NCT06959225
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 580 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2025 (Actual)
- Primary completion
- Oct 9, 2026 (Estimated)
- Completion
- Jul 11, 2027 (Estimated)
- Last update posted
- Jul 28, 2026
2025 – 2027
United States locations
- U.S. sites
- 59
- U.S. states
- 26
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site US020 | Phoenix | Arizona | 85008 | — |
| Investigative Site US033 | Scottsdale | Arizona | 85259 | — |
| Investigative Site US054 | Tempe | Arizona | 85282 | — |
| Investigative Site US002 | Fayetteville | Arkansas | 72703 | — |
| Investigative Site US055 | Brea | California | 92821 | — |
| Investigative Site US004 | Laguna Niguel | California | 92677 | — |
| Investigative Site US007 | Los Angeles | California | 90033 | — |
| Investigative Site US013 | San Diego | California | 92103 | — |
| Investigative Site US060 | San Diego | California | 92120 | — |
| Investigative Site US038 | San Diego | California | 92121 | — |
| Investigative Site US059 | Aurora | Colorado | 80045 | — |
| Investigative Site US045 | Boynton Beach | Florida | 33437 | — |
| Investigative Site US028 | Fort Myers | Florida | 33912 | — |
| Investigative Site US016 | Miami | Florida | 33142 | — |
| Investigative Site US027 | Sanford | Florida | 32771 | — |
| Investigative Site US057 | Sweetwater | Florida | 33172 | — |
| Investigative Site US029 | Tampa | Florida | 33609 | — |
| Investigative Site US061 | Atlanta | Georgia | 30322 | — |
| Investigative Site US053 | Atlanta | Georgia | 30331 | — |
| Investigative Site US019 | Marietta | Georgia | 30060 | — |
| Investigative Site US026 | Chicago | Illinois | 60657 | — |
| Investigative Site US049 | Clarksville | Indiana | 47129 | — |
| Investigative Site US052 | West Lafayette | Indiana | 47906 | — |
| Investigative Site US001 | Bowling Green | Kentucky | 42104 | — |
| Investigative Site US022 | Louisville | Kentucky | 40241 | — |
| Investigative Site US050 | Baton Rouge | Louisiana | 70809 | — |
| Investigative Site US046 | Glenn Dale | Maryland | 20769 | — |
| Investigative Site US003 | Boston | Massachusetts | 02115 | — |
| Investigative Site US030 | Boston | Massachusetts | 02215 | — |
| Investigative Site US010 | Quincy | Massachusetts | 02169 | — |
| Investigative Site US051 | Novi | Michigan | 48377 | — |
| Investigative Site US006 | Minneapolis | Minnesota | 55455 | — |
| Investigative Site US021 | New Brighton | Minnesota | 55112 | — |
| Investigative Site US036 | Saint Joseph | Missouri | 64506 | — |
| Investigative Site US034 | New City | New York | 10956 | — |
| Investigative Site US018 | New York | New York | 10003 | — |
| Investigative Site US017 | New York | New York | 10023 | — |
| Investigative Site US023 | Rochester | New York | 14623 | — |
| Investigative Site US014 | Chapel Hill | North Carolina | 27516 | — |
| Investigative Site US025 | Fargo | North Dakota | 58103 | — |
| Investigative Site US015 | Bexley | Ohio | 43209 | — |
| Investigative Site US044 | Cincinnati | Ohio | 45219 | — |
| Investigative Site US008 | Columbus | Ohio | 43230 | — |
| Investigative Site US031 | Mason | Ohio | 45040 | — |
| Investigative Site US048 | Oklahoma City | Oklahoma | 73118 | — |
| Investigative Site US043 | Danville | Pennsylvania | 17822 | — |
| Investigative Site US056 | Philadelphia | Pennsylvania | 19107 | — |
| Investigative Site US024 | Charleston | South Carolina | 29425 | — |
| Investigative Site US041 | Myrtle Beach | South Carolina | 29788 | — |
| Investigative Site US047 | Nashville | Tennessee | 37215 | — |
| Investigative Site US062 | Dallas | Texas | 75390 | — |
| Investigative Site US035 | El Paso | Texas | 79902 | — |
| Investigative Site US032 | Frisco | Texas | 75033 | — |
| Investigative Site US012 | Plano | Texas | 75025 | — |
| Investigative Site US011 | San Antonio | Texas | 78213 | — |
| Investigative Site US040 | Layton | Utah | 84041 | — |
| Investigative Site US037 | Murray | Utah | 84107 | — |
| Investigative Site US039 | Ogden | Utah | 84405 | — |
| Investigative Site US058 | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06959225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06959225 live on ClinicalTrials.gov.